Recently, a high-fat diet treated mouse model was used to directly compare the NAFLD improvement of the AMPK activator Metformin and mild obesity by taking BH extract for 12 weeks. The gene discussed is PRKAA1; the disease is metabolic dysfunction-associated steatotic liver disease.